Ambu stock trades at EUR 9.26 as UBS cuts target
Published on 09/30/2026 at 11:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ambu (ISIN DK0060946788) was trading at EUR 9.26 at Lang & Schwarz on September 30, 2026, down 0.11 percent from the prior close of EUR 9.27. Ambu's market capitalization was DKK 18.4 billion, while its 52-week range stood at DKK 56.25 to DKK 111.80.
Q3 growth meets a margin test
The latest operating picture combines double-digit expansion with a clear profitability milestone. According to Yahoo Finance on August 26, 2026, Ambu reported 10.3 percent organic growth in Q3 of fiscal 2025/26 and a reported EBIT margin of 13.5 percent, up 2.2 percentage points year over year.
Yahoo Finance also reported 16 percent growth in Endoscopy Solutions and a return to positive 1.6 percent growth in Anesthesia and Patient Monitoring. Endoscopy now accounts for 64 percent of the business, making that segment the main operating driver.
UBS lowers the bar
The main counterweight is execution. Investing.com reported on September 15, 2026, that UBS downgraded Ambu from Buy to Neutral and cut its 12-month price target from DKK 96 to DKK 72.
UBS projected 10.3 percent annual sales growth for 2026 through 2030, below Ambu's 11 percent to 13 percent target, and reduced its 2027 and 2028 earnings per share estimates by 7 percent and 12 percent. The assessment puts more weight on delivery against targets than on the long-term single-use endoscopy opportunity.
Annual results arrive November 5
Boerse Express lists November 5, 2026, as Ambu's next annual results date. That report will show whether the Q3 margin improvement and Endoscopy growth are translating into the upper end of the 12 percent to 14 percent full-year EBIT margin guidance.
The euro quote is EUR 9.26
Ambu stock was trading at EUR 9.26 at Lang & Schwarz on September 30, 2026, at 11:41 a.m. CEST, down 0.11 percent versus the Lang & Schwarz prior close of EUR 9.27. The dated market capitalization of DKK 18.4 billion and the DKK 56.25 to DKK 111.80 52-week range frame the valuation discussion around the next results.
Ambu stock facts
- Company: Ambu A/S
- ISIN: DK0060946788
- Ticker: AMBU B.CO
- Primary exchange: Nasdaq Copenhagen
- Price Lang & Schwarz as of September 30, 2026, 11:41 a.m. CEST: EUR 9.26
- Change versus prior close: minus 0.11 percent
- Prior close Lang & Schwarz September 29, 2026: EUR 9.27
- Market capitalization: DKK 18.4 billion as of September 30, 2026
- 52-week range: DKK 56.25-DKK 111.80 as of September 30, 2026
- Sector / Industry: Health Care / Medical Equipment, Supplies and Distribution
- Next earnings date: November 5, 2026
